Terry-ann Burrell - Net Worth and Insider Trading
Terry-ann Burrell Net Worth
The estimated net worth of Terry-ann Burrell is at least $2 Million dollars as of 2024-11-13. Terry-ann Burrell is the CFO of Beam Therapeutics Inc and owns about 70,137 shares of Beam Therapeutics Inc (BEAM) stock worth over $2 Million. Terry-ann Burrell is also the Director of Recursion Pharmaceuticals Inc and owns about 54,847 shares of Recursion Pharmaceuticals Inc (RXRX) stock worth over $415,740. Details can be seen in Terry-ann Burrell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Terry-ann Burrell has not made any transactions after 2024-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Terry-ann Burrell
Terry-ann Burrell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Terry-ann Burrell owns 2 companies in total, including Beam Therapeutics Inc (BEAM) , and Recursion Pharmaceuticals Inc (RXRX) .
Click here to see the complete history of Terry-ann Burrell’s form 4 insider trades.
Insider Ownership Summary of Terry-ann Burrell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BEAM | Beam Therapeutics Inc | 2024-04-01 | CFO |
| RXRX | Recursion Pharmaceuticals Inc | 2023-07-13 | director |
Terry-ann Burrell Latest Holdings Summary
Terry-ann Burrell currently owns a total of 2 stocks. Among these stocks, Terry-ann Burrell owns 70,137 shares of Beam Therapeutics Inc (BEAM) as of April 1, 2024, with a value of $2 Million and a weighting of 82.5%. Terry-ann Burrell also owns 54,847 shares of Recursion Pharmaceuticals Inc (RXRX) as of July 13, 2023, with a value of $415,740 and a weighting of 17.5%.
Latest Holdings of Terry-ann Burrell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc | 2024-04-01 | 70,137 | 27.94 | 1,959,628 |
| RXRX | Recursion Pharmaceuticals Inc | 2023-07-13 | 54,847 | 7.58 | 415,740 |
Holding Weightings of Terry-ann Burrell
Terry-ann Burrell Form 4 Trading Tracker
According to the SEC Form 4 filings, Terry-ann Burrell has made a total of 7 transactions in Beam Therapeutics Inc (BEAM) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Beam Therapeutics Inc is the sale of 5,446 shares on April 1, 2024, which brought Terry-ann Burrell around $174,926.
According to the SEC Form 4 filings, Terry-ann Burrell has made a total of 1 transactions in Recursion Pharmaceuticals Inc (RXRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Recursion Pharmaceuticals Inc is the sale of 117,000 shares on July 13, 2023, which brought Terry-ann Burrell around $1 Million.
Insider Trading History of Terry-ann Burrell
- 1
Terry-ann Burrell Trading Performance
Terry-ann Burrell Ownership Network
Ownership Network List of Terry-ann Burrell
Ownership Network Relation of Terry-ann Burrell
Terry-ann Burrell Owned Company Details
What does Beam Therapeutics Inc do?
Who are the key executives at Beam Therapeutics Inc?
Terry-ann Burrell is the CFO of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include President & CSO Giuseppe Ciaramella , Chief Legal Officer Christine Bellon , and director & CEO John M. Evans .
Beam Therapeutics Inc (BEAM) Insider Trades Summary
Over the past 18 months, Terry-ann Burrell made 1 insider transaction in Beam Therapeutics Inc (BEAM) with a net sale of 5,446. Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 16,081 shares made by Christine Bellon , a net sale of 263,284 shares made by Giuseppe Ciaramella , and a net sale of 198,102 shares made by John M. Evans .
In summary, during the past 3 months, insiders sold 162,894 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 162,894 shares. During the past 18 months, 1,413,543 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413,543 shares.
Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Beam Therapeutics Inc Insider Transactions
Terry-ann Burrell Mailing Address
Above is the net worth, insider trading, and ownership report for Terry-ann Burrell. You might contact Terry-ann Burrell via mailing address: C/o Beam Therapeutics Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
